CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN • US1851231068

23.18 USD
+0.04 (+0.17%)
At close: Feb 24, 2026
23.56 USD
+0.38 (+1.64%)
After Hours: 2/24/2026, 8:19:12 PM
Fundamental Rating

4

CWAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 274 industry peers in the Software industry. The financial health of CWAN is average, but there are quite some concerns on its profitability. CWAN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CWAN was profitable.
  • CWAN had a positive operating cash flow in the past year.
  • CWAN had negative earnings in 4 of the past 5 years.
  • In the past 5 years CWAN always reported a positive cash flow from operatings.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • CWAN has a Return On Assets (-1.29%) which is comparable to the rest of the industry.
  • CWAN's Return On Equity of -1.93% is in line compared to the rest of the industry. CWAN outperforms 55.84% of its industry peers.
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROIC N/A
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • CWAN has a Gross Margin (67.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CWAN has declined.
  • The Profit Margin and Operating Margin are not available for CWAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

  • CWAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CWAN has been increased compared to 1 year ago.
  • Compared to 5 years ago, CWAN has more shares outstanding
  • CWAN has a worse debt/assets ratio than last year.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 4.43 indicates that CWAN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CWAN (4.43) is better than 76.28% of its industry peers.
  • The Debt to FCF ratio of CWAN is 5.34, which is a neutral value as it means it would take CWAN, 5.34 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 5.34, CWAN perfoms like the industry average, outperforming 56.20% of the companies in the same industry.
  • CWAN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • CWAN has a worse Debt to Equity ratio (0.40) than 63.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Altman-Z 4.43
ROIC/WACCN/A
WACC10.94%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CWAN has a Current Ratio of 1.83. This is a normal value and indicates that CWAN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CWAN (1.83) is comparable to the rest of the industry.
  • A Quick Ratio of 1.83 indicates that CWAN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.83, CWAN is in line with its industry, outperforming 55.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.00% over the past year.
  • The Earnings Per Share has been growing by 32.91% on average over the past years. This is a very strong growth
  • CWAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 61.88%.
  • The Revenue has been growing by 29.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%

3.2 Future

  • Based on estimates for the next years, CWAN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.43% on average per year.
  • CWAN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.78% yearly.
EPS Next Y31.28%
EPS Next 2Y29.98%
EPS Next 3Y33.51%
EPS Next 5Y28.43%
Revenue Next Year29.41%
Revenue Next 2Y23.63%
Revenue Next 3Y21.57%
Revenue Next 5Y18.78%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 42.93, CWAN can be considered very expensive at the moment.
  • CWAN's Price/Earnings is on the same level as the industry average.
  • CWAN is valuated expensively when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 32.70 indicates a quite expensive valuation of CWAN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CWAN.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, CWAN is valued at the same level.
Industry RankSector Rank
PE 42.93
Fwd PE 32.7
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CWAN.
  • CWAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 44.09
EV/EBITDA 96.52
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • CWAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CWAN's earnings are expected to grow with 33.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3Y33.51%

0

5. Dividend

5.1 Amount

  • No dividends for CWAN!.
Industry RankSector Rank
Dividend Yield 0%

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (2/24/2026, 8:19:12 PM)

After market: 23.56 +0.38 (+1.64%)

23.18

+0.04 (+0.17%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-18
Earnings (Next)04-29
Inst Owners99.01%
Inst Owner Change10.24%
Ins Owners0.84%
Ins Owner Change31.64%
Market Cap6.79B
Revenue(TTM)731.37M
Net Income(TTM)-39.12M
Analysts73.75
Price Target26.49 (14.28%)
Short Float %4.14%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.79%
Min EPS beat(2)-6.22%
Max EPS beat(2)-1.36%
EPS beat(4)1
Avg EPS beat(4)-1.75%
Min EPS beat(4)-6.22%
Max EPS beat(4)2.56%
EPS beat(8)4
Avg EPS beat(8)2.8%
EPS beat(12)8
Avg EPS beat(12)7.86%
EPS beat(16)11
Avg EPS beat(16)6.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)2.43%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)6
Avg Revenue beat(12)0.08%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)-6.33%
PT rev (3m)-16.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 42.93
Fwd PE 32.7
P/S 9.29
P/FCF 44.09
P/OCF 38.63
P/B 3.36
P/tB 106.01
EV/EBITDA 96.52
EPS(TTM)0.54
EY2.33%
EPS(NY)0.71
Fwd EY3.06%
FCF(TTM)0.53
FCFY2.27%
OCF(TTM)0.6
OCFY2.59%
SpS2.49
BVpS6.9
TBVpS0.22
PEG (NY)1.37
PEG (5Y)N/A
Graham Number9.15
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.29%
FCFM 21.07%
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
F-Score3
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Debt/EBITDA 10.46
Cap/Depr 25.48%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion 225.93%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 4.43
F-Score3
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)41.76%
Cap/Depr(5y)84.08%
Cap/Sales(3y)1.89%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y31.28%
EPS Next 2Y29.98%
EPS Next 3Y33.51%
EPS Next 5Y28.43%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%
Revenue Next Year29.41%
Revenue Next 2Y23.63%
Revenue Next 3Y21.57%
Revenue Next 5Y18.78%
EBIT growth 1Y-162.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.58%
EBIT Next 3Y27.09%
EBIT Next 5Y24.92%
FCF growth 1Y123.14%
FCF growth 3Y45.29%
FCF growth 5YN/A
OCF growth 1Y136.67%
OCF growth 3Y44.74%
OCF growth 5YN/A

CLEARWATER ANALYTICS HDS-A / CWAN FAQ

What is the ChartMill fundamental rating of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CWAN.


What is the valuation status for CWAN stock?

ChartMill assigns a valuation rating of 3 / 10 to CLEARWATER ANALYTICS HDS-A (CWAN). This can be considered as Overvalued.


What is the profitability of CWAN stock?

CLEARWATER ANALYTICS HDS-A (CWAN) has a profitability rating of 2 / 10.


Can you provide the financial health for CWAN stock?

The financial health rating of CLEARWATER ANALYTICS HDS-A (CWAN) is 4 / 10.